Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer.
Yingming LiRendong YangChristine M HenzlerYeung HoCourtney PassowBenjamin AuchSuzanne CarreiraDaniel Nava RodriguesClaudia BertanTae Hyun HwangDavid A QuigleyHa X DangColm MorrisseyMichael FraserStephen R PlymateChristopher A MaherFelix Y FengJohann S de BonoScott M DehmPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
AR gene rearrangements are an important mechanism of resistance to endocrine therapies in CRPC.